Continuous Glucose Monitoring System(FreeStyle Libre Pro iQ )
- UID
- IMP/MD/2021/000503_336b57dcd77d2690d5ead3964ee971b7_b22a6f66f19312da6d86fbeff09f995a
- Device class
- Class C
- Brand name
- Reader
- License holder
- Abbott Healthcare Private Limited
- Approving authority
- CDSCO
- Product information
- The FreeStyle Libre Pro iQ Continuous Glucose Monitoring System is a factory-calibrated continuous glucose recording device indicated for the retrospective discovery, analysis and interpretation of glycaemic variability in persons aged 4 and older under the supervision of a healthcare professional. The System collects and processes data for aiding in the management of a disease or condition related to glycaemic control. Interpretation of the data recorded by the System should be made only by a qualified healthcare professional based on glucose trends and several sequential readings over time. The System aids in detecting glucose excursions facilitating care plan adjustments. The System is also intended to interface with digitally connected devices. The System has been evaluated for use in pregnant women.
Continuous Glucose Monitoring System(FreeStyle Libre Pro iQ ) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2021/000503_336b57dcd77d2690d5ead3964ee971b7_b22a6f66f19312da6d86fbeff09f995a. This device is marketed under the brand name Reader. The license holder is Abbott Healthcare Private Limited, and it is classified as Device Class Class C. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.